首页> Experimental hematology & oncology> Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis.

Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis.

导出 OA

翻译打印收藏纠错

第一作者： Timothy,Schieber

第一单位： The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America. T96249@kumc.edu.

作者： Timothy,Schieber ^[1] ; Kelly,Brunk ^[2] ; Anna,Clennon ^[3] ; Benjamin L,Woolbright ^[4] ; Leonidas E,Bantis ^[4] ; Dennis,Grauer ^[5] ; Tiewei,Cheng ^[6] ; Saqib,Abbasi ^[6] ; Elizabeth,Wulff-Burchfield ^[6] ; Rahul,Parikh ^[6] ; Haoran,Li ^[7]

作者单位： The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America. T96249@kumc.edu. ^[1] National Community Oncology Dispensing Association, 9 Albany St #2e, Cazenovia, NY, 13035, United States of America. ^[2] Aurora St Luke's Medical Center, 2900 W Oklahoma Ave, Milwaukee, WI, 53215, United States of America. ^[3] Department of Biostatistics and Data Science, University of Kansas Medical Center, 3901 Rainbow Blvd Mailstop 1026, Kansas City, KS, 66103, United States of America. ^[4] The University of Kansas School of Pharmacy, 2010 Becker Dr, Lawrence, KS, 66047, United States of America. ^[5] The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America. ^[6] The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America. hli6@kumc.edu. ^[7]

关键词 HPV Immunotherapy Metastatic Pembrolizumab Penile Squamous cell carcinoma

DOI 10.1186/s40164-025-00629-4

PMID 40075416

发布时间 2025-03-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交